GlassScriptPhysician profile
Michael James Jacobson
NPI 1366442600
$15,894.38
in general payments reported to CMS, 2019-2025
49 companies · $2,881 in 2025
The $2,881 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,886 · 2020: $1,535 · 2021: $2,354 · 2022: $2,668 · 2023: $2,338 · 2024: $2,231 · 2025: $2,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,654 · Travel and Lodging: $740 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,654.34 |
| Travel and Lodging | $739.76 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,423.07 | 2022-2025 | |
| Inspire Medical Systems, INC. | $1,994.16 | 2022-2025 | Inspire |
| Intersect Ent, INC. | $1,877.53 | 2019-2022 | |
| Optinose US, INC. | $980.63 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $972.21 | 2019-2025 | Dupixent |
| Stryker Corporation | $725.88 | 2019-2022 | |
| Glaxosmithkline, LLC. | $552.57 | 2019-2025 | Nucala, Trelegy Ellipta |
| Medtronic, INC. | $547.25 | 2023-2024 | Sinuva, Stealthstation S8 Platform, Nuvent |
| Genzyme Corporation | $469.39 | 2020-2025 | |
| Genentech USA, INC. | $384.42 | 2019-2025 | Xolair |
| Pfizer INC. | $378.29 | 2022-2024 | |
| Hill Dermaceuticals, INC. | $373.84 | 2025 | Tolak |
| Supernus Pharmaceuticals, INC. | $347.24 | 2019-2022 | |
| Lundbeck LLC | $297.16 | 2021-2025 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $290.57 | 2021 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $276.61 | 2024-2025 | Voquezna |
| Amgen INC. | $260.02 | 2019-2025 | Tezspire |
| Jazz Pharmaceuticals INC. | $253.80 | 2019-2022 | |
| Kaleo, INC. | $251.85 | 2019-2024 | Auvi-Q |
| Biohaven Pharmaceutical Holding Company LTD. | $189.26 | 2022 | |
| Biocryst US Sales Co., LLC | $187.49 | 2022-2025 | Orladeyo |
| Integra Lifesciences Corporation | $186.48 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Acclarent, INC | $185.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $179.34 | 2019-2025 | |
| Abbvie INC. | $165.92 | 2025 | |
| Neurent Medical Limited | $145.02 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Takeda Pharmaceuticals U.S.A., INC. | $124.01 | 2020-2023 | Cuvitru |
| Depuy Synthes Sales INC. | $111.50 | 2019 | |
| Shire North American Group INC | $102.01 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $77.92 | 2019-2021 | |
| Csl Behring | $68.05 | 2023-2024 | Haegarda |
| Lilly USA, LLC | $62.45 | 2025 | Zepbound, Ebglyss |
| Astrazeneca Pharmaceuticals LP | $60.98 | 2020-2025 | Airsupra |
| Philips North America LLC | $43.25 | 2019-2023 | |
| Resmed Corp | $38.11 | 2019 | |
| Hikma Pharmaceuticals USA | $35.55 | 2022-2023 | Ryaltris |
| Alk-Abello, INC | $33.03 | 2020-2021 | |
| Blueprint Medicines Corporation | $32.74 | 2024 | Ayvakit |
| Welch Allyn | $29.80 | 2021 | |
| Phadia US INC. | $24.33 | 2022 | |
| Axsome Therapeutics, INC. | $23.75 | 2024 | Sunosi |
| Ars Pharmaceuticals Operations, INC. | $23.23 | 2025 | Neffy |
| Cochlear Americas | $21.10 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Pharming Healthcare, INC. | $16.94 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.69 | 2025 | Nuzyra, Xhance |
| Watermark Medical, INC. | $14.02 | 2024 | |
| Karl Storz Endoscopy-America | $13.93 | 2019 | |
| Cycle Pharmaceuticals INC | $13.71 | 2025 | Sajazir |
| Biocryst Pharmaceuticals, INC. | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.